Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
3
27%
Ph phase_4
5
45%
Ph phase_3
1
9%
Ph phase_1
1
9%

Phase Distribution

1

Early Stage

3

Mid Stage

6

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
3(30.0%)
Phase 3Large-scale testing
1(10.0%)
Phase 4Post-market surveillance
5(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(6)
Other(5)

Detailed Status

Completed6
unknown4
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 23 (30.0%)
Phase 31 (10.0%)
Phase 45 (50.0%)

Trials by Status

completed655%
unknown436%
suspended19%

Recent Activity

0 active trials
Showing 5 of 11
suspendedphase_2

A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)

NCT05143177
completedphase_4

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

NCT03910361
unknown

Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.

NCT04326166
unknownphase_4

A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin

NCT04706637
unknownphase_4

Randomized, Open-label Trial of Inhibitory Effect of Evogliptin on Progression of CAVD

NCT04521452
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT05143177Phase 2

A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)

Suspended
NCT03910361Phase 4

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

Completed
NCT04326166

Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.

Unknown
NCT04706637Phase 4

A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin

Unknown
NCT04521452Phase 4

Randomized, Open-label Trial of Inhibitory Effect of Evogliptin on Progression of CAVD

Unknown
NCT03667300Phase 2

Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency

Completed
NCT02689362Phase 2

Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2)

Completed
NCT02974504Phase 4

Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)

Completed
NCT02754219Phase 1

Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction

Completed
NCT02949193Phase 3

Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes

Completed
NCT02587975Phase 4

Effect of Evogliptin on Bone Metabolism in Human

Unknown

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11